Skip to content

Change in Other Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$18M0.0%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$2.45M+65.1%
Avanos Medical logo
Avanos MedicalAVNS
$2.4M+900%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$4.54M-12.8%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$12.43M+269%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$1.03M-211%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+17.9%
Enterprise value$869.67M-0.3%
P/E15.4×-6.9×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s change in other assets?
Collegium Pharmaceutical, Inc. (COLL) reported change in other assets of -$4.13M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s change in other assets changed year-over-year?
Collegium Pharmaceutical, Inc.'s change in other assets decreased by 140.2% year-over-year, from $10.27M to -$4.13M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s change in other assets?
Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s change in other assets has grown at a 64.6% compound annual growth rate (CAGR), from $1.09M to $7.97M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.